Differential response of the liver to bile acid treatment in a mouse model of Niemann-Pick disease type C

Niemann-Pick disease type C (NPC) disease is a neurodegenerative lysosomal storage disease caused by mutations in the NPC1 or NPC2 genes. Liver disease is also a common feature of NPC that can present as cholestatic jaundice in the neonatal period. Liver enzymes can remain elevated above the normal...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Nicoli, E, Smith, D, Morris, L, Platt, F
Formaat: Journal article
Taal:English
Gepubliceerd in: F1000Research 2017
_version_ 1826299148430737408
author Nicoli, E
Smith, D
Morris, L
Platt, F
author_facet Nicoli, E
Smith, D
Morris, L
Platt, F
author_sort Nicoli, E
collection OXFORD
description Niemann-Pick disease type C (NPC) disease is a neurodegenerative lysosomal storage disease caused by mutations in the NPC1 or NPC2 genes. Liver disease is also a common feature of NPC that can present as cholestatic jaundice in the neonatal period. Liver enzymes can remain elevated above the normal range in some patients as they age. We recently reported suppression of the P450 detoxification system in a mouse model of NPC disease and in post-mortem liver from NPC patients. As bile acids regulate the P450 system, we tested bile acid treatment using ursodeoxycholic acid (UDCA; 3α, 7β-dihydroxy-5β-cholanic acid), a hydrophilic bile acid, which is used to treat several cholestatic disorders. In this study, we compared UDCA treatment with the bile acid cholic acid (CA), and found unexpected hepatotoxicity in response to CA in Npc1 mice, but not to UDCA, suggesting that only UDCA should be used as an adjunctive therapy in NPC patients.
first_indexed 2024-03-07T04:57:31Z
format Journal article
id oxford-uuid:d71b29cf-e005-4f73-b6f0-10c8be0c91b2
institution University of Oxford
language English
last_indexed 2024-03-07T04:57:31Z
publishDate 2017
publisher F1000Research
record_format dspace
spelling oxford-uuid:d71b29cf-e005-4f73-b6f0-10c8be0c91b22022-03-27T08:38:38ZDifferential response of the liver to bile acid treatment in a mouse model of Niemann-Pick disease type CJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d71b29cf-e005-4f73-b6f0-10c8be0c91b2EnglishSymplectic Elements at OxfordF1000Research2017Nicoli, ESmith, DMorris, LPlatt, FNiemann-Pick disease type C (NPC) disease is a neurodegenerative lysosomal storage disease caused by mutations in the NPC1 or NPC2 genes. Liver disease is also a common feature of NPC that can present as cholestatic jaundice in the neonatal period. Liver enzymes can remain elevated above the normal range in some patients as they age. We recently reported suppression of the P450 detoxification system in a mouse model of NPC disease and in post-mortem liver from NPC patients. As bile acids regulate the P450 system, we tested bile acid treatment using ursodeoxycholic acid (UDCA; 3α, 7β-dihydroxy-5β-cholanic acid), a hydrophilic bile acid, which is used to treat several cholestatic disorders. In this study, we compared UDCA treatment with the bile acid cholic acid (CA), and found unexpected hepatotoxicity in response to CA in Npc1 mice, but not to UDCA, suggesting that only UDCA should be used as an adjunctive therapy in NPC patients.
spellingShingle Nicoli, E
Smith, D
Morris, L
Platt, F
Differential response of the liver to bile acid treatment in a mouse model of Niemann-Pick disease type C
title Differential response of the liver to bile acid treatment in a mouse model of Niemann-Pick disease type C
title_full Differential response of the liver to bile acid treatment in a mouse model of Niemann-Pick disease type C
title_fullStr Differential response of the liver to bile acid treatment in a mouse model of Niemann-Pick disease type C
title_full_unstemmed Differential response of the liver to bile acid treatment in a mouse model of Niemann-Pick disease type C
title_short Differential response of the liver to bile acid treatment in a mouse model of Niemann-Pick disease type C
title_sort differential response of the liver to bile acid treatment in a mouse model of niemann pick disease type c
work_keys_str_mv AT nicolie differentialresponseofthelivertobileacidtreatmentinamousemodelofniemannpickdiseasetypec
AT smithd differentialresponseofthelivertobileacidtreatmentinamousemodelofniemannpickdiseasetypec
AT morrisl differentialresponseofthelivertobileacidtreatmentinamousemodelofniemannpickdiseasetypec
AT plattf differentialresponseofthelivertobileacidtreatmentinamousemodelofniemannpickdiseasetypec